Full Text:


Ǵм Vol.24_No.2 Suppl. P.S283-295, Dec. 2007



Treatment of Rectal Cancer

, Ȳ, ɹö
б ǰ ܰб
åڣɹö, 뱸 317-1, б ǰ ܰб
Tel: (053) 620-3590, Fax: (053) 624-1213
E-mail: mcshim@med.yu.ac.kr

December 30, 2007


Treatment for rectal cancer continues to develop towards the improved local control and overall survival, maintaining quality of life, and preserving sphincter, genitourinary, and sexual function. Preoperative assessment for tumor depth, lymph node, and distant metastasis has an important role on treatment plan. Preoperative staging is used to determine the indication for neoadjuvant therapy as well as the indication for local excision versus radical cancer resection. Local excision is likely to be curative in patients whose tumor are confined to the submucosa without regional lymph and systemic metastasis. Total mesorectal excision (TME) and autonomic nerve preservation are standard procedure for advanced rectal cancer. In patients with advanced tumor stage (T3/T4 and/or N1) with no distant metastasis, preoperative chemoradiation followed by radical resection has become widely accepted recently.

Key Words: Rectal cancer, Local excision, Total mesorectal excision, Preoperative chemora-diation


1. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
2. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 1982;69: 613-16.

3. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. Jama 1990;264:1444-50.
4. Nah MC KJ, Shim MC, Hwun KB. The Effects of Preoperative Chemoradiation Therapy in Rectal Cancer. J Korean Surg Soc 1997;52 (1):58-65.

5. Bosset JF, Calais G, Mineur L, Maingon, P, Radosevic-Jelic, L, Daban, A, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. J Clin Oncol 2005;23:5620-27.
6. Kim HJ, Wong WD. Role of endorectal ultrasound in the conservative management of rectal cancers. Semin Surg Oncol 2000;19:358- 66.

7. Schaffzin DM, Wong WD. Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin Colorectal Cancer 2004;4:124-32.
8. Harewood GC, Yusuf TE, Clain JE, Levy MJ, Topazian MD, Rajan E. Assessment of the impact of an educational course on knowledge of appropriate EUS indications. Gastrointest Endosc 2005;61:554-9.

9. Zerhouni EA, Rutter C, Hamilton SR, Balfe, D. M., Megibow, A. J., Francis, I. R, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996;200:443-51.
10. Blomqvist L, Machado M, Rubio C, et al. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 2000; 10:653-60.

11. Bissett IP, Fernando CC, Hough DM, Gabrielsson, N., Granqvist, S., Goldman, S., et al. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum 2001;44:259-65.
12. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradio- therapy? Dis Colon Rectum 2005;48:722-8.

13. Guillem JG, Puig-La Calle J Jr, Akhurst T, Tickoo, S., Ruo, L., Minsky, B. D., et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43:18-24.

14. McLean CM, Duncan W. Rectal cancer: a review of randomized trials of adjuvant radiotherapy. Clin Oncol (R Coll Radiol) 1995; 7:349-58.
15. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335-46.

16. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978- 1997. Arch Surg 1998;133:894-9.
17. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356:93-6.

18. Wibe A, Rendedal PR, Svensson E, Norstein, J., Eide, T. J., Myrvold, H. E., et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-34.
19. Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002;28:126-34.

20. Bulow S, Christensen IJ, Harling H, Kronborg O, Fenger C, Nielsen HJ. Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 2003;90:974-80.
21. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002;89:1142-9.

22. Wibe A, Moller B, Norstein J, Carlsen, E., Wiig, J. N., Heald, R. J., et al. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45: 857-66.
23. Harling H, Bulow S, Kronborg O, Jorgensen T. [Treatment of rectal cancer in Denmark 1994-1999]. Ugeskr Laeger 2004;166:368-71.

24. Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998;227:800-11.
25. Goligher JC, Dukes CE, Bussey HJ. Local recurrences after sphincter saving excisions for carcinoma of the rectum and rectosigmoid. Br J Surg 1951;39:199-211.

26. Madsen PM, Christiansen J. Distal intramural spread of rectal carcinomas. Dis Colon Rectum 1986;29:279-82.
27. Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients survival. Br J Surg 1983;70:150-4.

28. Guillem JG, Moore HG, Paty PB, Cohen AM, Wong WD. Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer. Ann Surg Oncol 2003;10:824-9.
29. Schiessel R, Novi G, Holzer B, Rosen, H. R., Renner, K., Holbling, N., et al. Technique and long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 2005;48:1858-1865; discussion 1865-7.

30. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-7.
31. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopatho- logical study of lateral tumour spread and surgical excision. Lancet 1986;2:996-9.

32. Adam IJ, Mohamdee MO, Martin IG, Scott, N., Finan, P. J., Johnston, D., et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344:707-11.
33. Pfeifer J, Wexner SD, Reissman P, Bernstein, M., Nogueras, J. J., Singh, S., et al. Laparoscopic vs open colon surgery. Costs and outcome. Surg Endosc 1995;9:1322-6.

34. Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells, A., Taura, P., Pique, J. M., et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002;359: 2224-9.
35. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350:2050-9.

36. Wu WX, Sun YM, Hua YB, Shen LZ. Laparo- scopic versus conventional open resection of rectal carcinoma: A clinical comparative study. World J Gastroenterol 2004;10:1167-70.
37. Tsang WW, Chung CC, Li MK. Prospective evaluation of laparoscopic total mesorectal excision with colonic J-pouch reconstruction for mid and low rectal cancers. Br J Surg 2003;90:867-71.

38. Moore HG, Guillem JG. Local therapy for rectal cancer. Surg Clin North Am 2002;82: 967-81.
39. Choi PH, Yu CS, Jung SH, Kim DD, Hong DH, Kim HC, et al. Long-term Oncological Outcomes of T1 Rectal Cancer according to the Therapeutic Modalities. J Korean Soc Coloproctol 2006;22(5):330-6.

40. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000; 231:345-51.
41. Garcia-Aguilar J, Pollack J, Lee SH, Hernandez de Anda, E., Mellgren, A., Wong, W. D., et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002;45:10-5.

42. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 2000;43:1064-71.
43. Paty PB, Nash GM, Baron P, Zakowski, M., Minsky, B. D., Blumberg, D. et al. Long-term results of local excision for rectal cancer. Ann Surg 2002;236:522-9.

44. Chambers WM, Khan U, Gagliano A, Smith RD, Sheffield J, Nicholls RJ. Tumour morphology as a predictor of outcome after local excision of rectal cancer. Br J Surg 2004;91:457-9.
45. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;45:200-6.

46. Bleday R, Breen E, Jessup JM, Burgess A, Sentovich SM, Steele G Jr. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum 1997;40:388-92.
47. Lezoche E, Guerrieri M, Paganini AM, Feliciotti F. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision. World J Surg 2002;26:1170-4.

48. Takahashi T, Ueno M, Azekura K, Ohta H. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 2000;43:S59-68.
49. Suzuki K, Muto T, Sawada T. Prevention of local recurrence by extended lymphadenectomy for rectal cancer. Surg Today 1995;25:795-801.

50. Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis. Am J Surg 1951; 81:111-20.
51. Choi BG, Seo KW, Ju JK, Ryu SY, Park YK, Kim HY, et al. Effect on the Local Recurrence and the Survival of Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection in Rectal Cancer. 2007;23:46-52.

52. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23:5644-50.
53. Glimelius B, Isacsson U, Jung B, Pahlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys 1997;37:281-7.

54. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 2001;234:633-40.
55. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer. J Clin Oncol 199816:301-8.

56. Fisher B, Wolmark N, Rockette H, Redmond, C., Deutsch, M., Wickerham, D. L. et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-9.
57. Wolmark N, Wieand HS, Hyams DM, Colangelo, L., Dimitrov, N. V., Romond, E. H., et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388-96.

58. OConnell MJ, Martenson JA, Wieand HS, Krook, J. E., Macdonald, J. S., Haller, D. G., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7.
59. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preope- rative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995;75:2269-75.

60. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896-902.
61. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-7.

62. Berger C, de Muret A, Garaud P, Chapet, S., Bourlier, P., Reynaud-Bougnoux, A., et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619-27.

63. Sauer R, Becker H, Hohenberger W, Rodel, C., Wittekind, C., Fietkau, R., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
64. Luna-Perez P, Rodriguez-Ramirez S, Rodriguez- Coria DF, et al. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma. World J Surg 2001;25:1006-11.

65. Habr-Gama A, Perez RO, Nadalin W, Sabbaga, J, Ribeiro, U Jr, Silva e Sousa, A. H Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemo- radiation therapy: long-term results. Ann Surg 2004;240:711-717; discussion 717-8.

66. Rougier P, Lepille D, Bennouna J, Marre, A., Ducreux, M., Mignot, L., et al. Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study. Ann Oncol 2002;13:1558-67.
67. Thirion P, Michiels S, Pianon JP, Buyse, M., Braud, A. C., Carlson, R. W., et al. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta- analysis. J Clin Oncol 2004;22:3766-75.